AEON Biopharma Announces Strategic Reprioritization to Pursue a Biosimilar Pathway for ABP-450 by Seini Moimoi | Jul 10, 2024 | Portfolio News
IntelyCare Appoints Industry Leader Matthew Levesque as CEO by Seini Moimoi | Jul 10, 2024 | Portfolio News
Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC by Seini Moimoi | Jul 8, 2024 | Portfolio News
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency by Seini Moimoi | Jul 2, 2024 | Portfolio News
Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046, an Oral KRASG12D-Selective Dual-State Allosteric Inhibitor, and Other Program Updates by Seini Moimoi | Jun 27, 2024 | Portfolio News
